The global market for Sunitinib Malate Capsules is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Sunitinib Malate Capsules market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Sunitinib Malate Capsules market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Sunitinib Malate Capsules market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Sunitinib Malate Capsules market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Sunitinib Malate Capsules players cover Pfizer Sutent, Topcare Pharmaceutical Co., Ltd, Nanjing First Pharmaceutical Co., Ltd., J&K Scientific and Target Molecule Corp., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Sunitinib Malate Capsules market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Sunitinib Malate Capsules market, with both quantitative and qualitative data, to help readers understand how the Sunitinib Malate Capsules market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Sunitinib Malate Capsules market and forecasts the market size by Type (Purity>99%, Purity>98% and Purity>97%), by Application (Advanced Kidney Cancer, GIST (Gastrointestinal Stromal Tumor), Pancreatic Neuroendocrine Tumors and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Purity>99%
Purity>98%
Purity>97%
Segmentation by application
Advanced Kidney Cancer
GIST (Gastrointestinal Stromal Tumor)
Pancreatic Neuroendocrine Tumors
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Pfizer Sutent
Topcare Pharmaceutical Co., Ltd
Nanjing First Pharmaceutical Co., Ltd.
J&K Scientific
Target Molecule Corp.
Teva Pharmaceuticals USA
CSPC Pharmaceutical Group Limited
Chapter Introduction
Chapter 1: Scope of Sunitinib Malate Capsules, Research Methodology, etc.
Chapter 2: Executive Summary, global Sunitinib Malate Capsules market size (sales and revenue) and CAGR, Sunitinib Malate Capsules market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Sunitinib Malate Capsules sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Sunitinib Malate Capsules sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Sunitinib Malate Capsules market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer Sutent, Topcare Pharmaceutical Co., Ltd, Nanjing First Pharmaceutical Co., Ltd., J&K Scientific, Target Molecule Corp., Teva Pharmaceuticals USA and CSPC Pharmaceutical Group Limited, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sunitinib Malate Capsules Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sunitinib Malate Capsules by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sunitinib Malate Capsules by Country/Region, 2017, 2022 & 2028
2.2 Sunitinib Malate Capsules Segment by Type
2.2.1 Purity>99%
2.2.2 Purity>98%
2.2.3 Purity>97%
2.3 Sunitinib Malate Capsules Sales by Type
2.3.1 Global Sunitinib Malate Capsules Sales Market Share by Type (2017-2022)
2.3.2 Global Sunitinib Malate Capsules Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sunitinib Malate Capsules Sale Price by Type (2017-2022)
2.4 Sunitinib Malate Capsules Segment by Application
2.4.1 Advanced Kidney Cancer
2.4.2 GIST (Gastrointestinal Stromal Tumor)
2.4.3 Pancreatic Neuroendocrine Tumors
2.4.4 Others
2.5 Sunitinib Malate Capsules Sales by Application
2.5.1 Global Sunitinib Malate Capsules Sale Market Share by Application (2017-2022)
2.5.2 Global Sunitinib Malate Capsules Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sunitinib Malate Capsules Sale Price by Application (2017-2022)
3 Global Sunitinib Malate Capsules by Company
3.1 Global Sunitinib Malate Capsules Breakdown Data by Company
3.1.1 Global Sunitinib Malate Capsules Annual Sales by Company (2020-2022)
3.1.2 Global Sunitinib Malate Capsules Sales Market Share by Company (2020-2022)
3.2 Global Sunitinib Malate Capsules Annual Revenue by Company (2020-2022)
3.2.1 Global Sunitinib Malate Capsules Revenue by Company (2020-2022)
3.2.2 Global Sunitinib Malate Capsules Revenue Market Share by Company (2020-2022)
3.3 Global Sunitinib Malate Capsules Sale Price by Company
3.4 Key Manufacturers Sunitinib Malate Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sunitinib Malate Capsules Product Location Distribution
3.4.2 Players Sunitinib Malate Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sunitinib Malate Capsules by Geographic Region
4.1 World Historic Sunitinib Malate Capsules Market Size by Geographic Region (2017-2022)
4.1.1 Global Sunitinib Malate Capsules Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sunitinib Malate Capsules Annual Revenue by Geographic Region
4.2 World Historic Sunitinib Malate Capsules Market Size by Country/Region (2017-2022)
4.2.1 Global Sunitinib Malate Capsules Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sunitinib Malate Capsules Annual Revenue by Country/Region
4.3 Americas Sunitinib Malate Capsules Sales Growth
4.4 APAC Sunitinib Malate Capsules Sales Growth
4.5 Europe Sunitinib Malate Capsules Sales Growth
4.6 Middle East & Africa Sunitinib Malate Capsules Sales Growth
5 Americas
5.1 Americas Sunitinib Malate Capsules Sales by Country
5.1.1 Americas Sunitinib Malate Capsules Sales by Country (2017-2022)
5.1.2 Americas Sunitinib Malate Capsules Revenue by Country (2017-2022)
5.2 Americas Sunitinib Malate Capsules Sales by Type
5.3 Americas Sunitinib Malate Capsules Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sunitinib Malate Capsules Sales by Region
6.1.1 APAC Sunitinib Malate Capsules Sales by Region (2017-2022)
6.1.2 APAC Sunitinib Malate Capsules Revenue by Region (2017-2022)
6.2 APAC Sunitinib Malate Capsules Sales by Type
6.3 APAC Sunitinib Malate Capsules Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sunitinib Malate Capsules by Country
7.1.1 Europe Sunitinib Malate Capsules Sales by Country (2017-2022)
7.1.2 Europe Sunitinib Malate Capsules Revenue by Country (2017-2022)
7.2 Europe Sunitinib Malate Capsules Sales by Type
7.3 Europe Sunitinib Malate Capsules Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sunitinib Malate Capsules by Country
8.1.1 Middle East & Africa Sunitinib Malate Capsules Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sunitinib Malate Capsules Revenue by Country (2017-2022)
8.2 Middle East & Africa Sunitinib Malate Capsules Sales by Type
8.3 Middle East & Africa Sunitinib Malate Capsules Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sunitinib Malate Capsules
10.3 Manufacturing Process Analysis of Sunitinib Malate Capsules
10.4 Industry Chain Structure of Sunitinib Malate Capsules
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sunitinib Malate Capsules Distributors
11.3 Sunitinib Malate Capsules Customer
12 World Forecast Review for Sunitinib Malate Capsules by Geographic Region
12.1 Global Sunitinib Malate Capsules Market Size Forecast by Region
12.1.1 Global Sunitinib Malate Capsules Forecast by Region (2023-2028)
12.1.2 Global Sunitinib Malate Capsules Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sunitinib Malate Capsules Forecast by Type
12.7 Global Sunitinib Malate Capsules Forecast by Application
13 Key Players Analysis
13.1 Pfizer Sutent
13.1.1 Pfizer Sutent Company Information
13.1.2 Pfizer Sutent Sunitinib Malate Capsules Product Offered
13.1.3 Pfizer Sutent Sunitinib Malate Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Sutent Main Business Overview
13.1.5 Pfizer Sutent Latest Developments
13.2 Topcare Pharmaceutical Co., Ltd
13.2.1 Topcare Pharmaceutical Co., Ltd Company Information
13.2.2 Topcare Pharmaceutical Co., Ltd Sunitinib Malate Capsules Product Offered
13.2.3 Topcare Pharmaceutical Co., Ltd Sunitinib Malate Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Topcare Pharmaceutical Co., Ltd Main Business Overview
13.2.5 Topcare Pharmaceutical Co., Ltd Latest Developments
13.3 Nanjing First Pharmaceutical Co., Ltd.
13.3.1 Nanjing First Pharmaceutical Co., Ltd. Company Information
13.3.2 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Capsules Product Offered
13.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Nanjing First Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Nanjing First Pharmaceutical Co., Ltd. Latest Developments
13.4 J&K Scientific
13.4.1 J&K Scientific Company Information
13.4.2 J&K Scientific Sunitinib Malate Capsules Product Offered
13.4.3 J&K Scientific Sunitinib Malate Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 J&K Scientific Main Business Overview
13.4.5 J&K Scientific Latest Developments
13.5 Target Molecule Corp.
13.5.1 Target Molecule Corp. Company Information
13.5.2 Target Molecule Corp. Sunitinib Malate Capsules Product Offered
13.5.3 Target Molecule Corp. Sunitinib Malate Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Target Molecule Corp. Main Business Overview
13.5.5 Target Molecule Corp. Latest Developments
13.6 Teva Pharmaceuticals USA
13.6.1 Teva Pharmaceuticals USA Company Information
13.6.2 Teva Pharmaceuticals USA Sunitinib Malate Capsules Product Offered
13.6.3 Teva Pharmaceuticals USA Sunitinib Malate Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Pharmaceuticals USA Main Business Overview
13.6.5 Teva Pharmaceuticals USA Latest Developments
13.7 CSPC Pharmaceutical Group Limited
13.7.1 CSPC Pharmaceutical Group Limited Company Information
13.7.2 CSPC Pharmaceutical Group Limited Sunitinib Malate Capsules Product Offered
13.7.3 CSPC Pharmaceutical Group Limited Sunitinib Malate Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 CSPC Pharmaceutical Group Limited Main Business Overview
13.7.5 CSPC Pharmaceutical Group Limited Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Sunitinib Malate Capsules Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sunitinib Malate Capsules Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity>99%
Table 4. Major Players of Purity>98%
Table 5. Major Players of Purity>97%
Table 6. Global Sunitinib Malate Capsules Sales by Type (2017-2022) & (K Units)
Table 7. Global Sunitinib Malate Capsules Sales Market Share by Type (2017-2022)
Table 8. Global Sunitinib Malate Capsules Revenue by Type (2017-2022) & ($ million)
Table 9. Global Sunitinib Malate Capsules Revenue Market Share by Type (2017-2022)
Table 10. Global Sunitinib Malate Capsules Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Sunitinib Malate Capsules Sales by Application (2017-2022) & (K Units)
Table 12. Global Sunitinib Malate Capsules Sales Market Share by Application (2017-2022)
Table 13. Global Sunitinib Malate Capsules Revenue by Application (2017-2022)
Table 14. Global Sunitinib Malate Capsules Revenue Market Share by Application (2017-2022)
Table 15. Global Sunitinib Malate Capsules Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Sunitinib Malate Capsules Sales by Company (2020-2022) & (K Units)
Table 17. Global Sunitinib Malate Capsules Sales Market Share by Company (2020-2022)
Table 18. Global Sunitinib Malate Capsules Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Sunitinib Malate Capsules Revenue Market Share by Company (2020-2022)
Table 20. Global Sunitinib Malate Capsules Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Sunitinib Malate Capsules Producing Area Distribution and Sales Area
Table 22. Players Sunitinib Malate Capsules Products Offered
Table 23. Sunitinib Malate Capsules Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Sunitinib Malate Capsules Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Sunitinib Malate Capsules Sales Market Share Geographic Region (2017-2022)
Table 28. Global Sunitinib Malate Capsules Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Sunitinib Malate Capsules Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Sunitinib Malate Capsules Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Sunitinib Malate Capsules Sales Market Share by Country/Region (2017-2022)
Table 32. Global Sunitinib Malate Capsules Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Sunitinib Malate Capsules Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Sunitinib Malate Capsules Sales by Country (2017-2022) & (K Units)
Table 35. Americas Sunitinib Malate Capsules Sales Market Share by Country (2017-2022)
Table 36. Americas Sunitinib Malate Capsules Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Sunitinib Malate Capsules Revenue Market Share by Country (2017-2022)
Table 38. Americas Sunitinib Malate Capsules Sales by Type (2017-2022) & (K Units)
Table 39. Americas Sunitinib Malate Capsules Sales Market Share by Type (2017-2022)
Table 40. Americas Sunitinib Malate Capsules Sales by Application (2017-2022) & (K Units)
Table 41. Americas Sunitinib Malate Capsules Sales Market Share by Application (2017-2022)
Table 42. APAC Sunitinib Malate Capsules Sales by Region (2017-2022) & (K Units)
Table 43. APAC Sunitinib Malate Capsules Sales Market Share by Region (2017-2022)
Table 44. APAC Sunitinib Malate Capsules Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Sunitinib Malate Capsules Revenue Market Share by Region (2017-2022)
Table 46. APAC Sunitinib Malate Capsules Sales by Type (2017-2022) & (K Units)
Table 47. APAC Sunitinib Malate Capsules Sales Market Share by Type (2017-2022)
Table 48. APAC Sunitinib Malate Capsules Sales by Application (2017-2022) & (K Units)
Table 49. APAC Sunitinib Malate Capsules Sales Market Share by Application (2017-2022)
Table 50. Europe Sunitinib Malate Capsules Sales by Country (2017-2022) & (K Units)
Table 51. Europe Sunitinib Malate Capsules Sales Market Share by Country (2017-2022)
Table 52. Europe Sunitinib Malate Capsules Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Sunitinib Malate Capsules Revenue Market Share by Country (2017-2022)
Table 54. Europe Sunitinib Malate Capsules Sales by Type (2017-2022) & (K Units)
Table 55. Europe Sunitinib Malate Capsules Sales Market Share by Type (2017-2022)
Table 56. Europe Sunitinib Malate Capsules Sales by Application (2017-2022) & (K Units)
Table 57. Europe Sunitinib Malate Capsules Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Sunitinib Malate Capsules Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Sunitinib Malate Capsules Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Sunitinib Malate Capsules Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Sunitinib Malate Capsules Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Sunitinib Malate Capsules Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Sunitinib Malate Capsules Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Sunitinib Malate Capsules Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Sunitinib Malate Capsules Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Sunitinib Malate Capsules
Table 67. Key Market Challenges & Risks of Sunitinib Malate Capsules
Table 68. Key Industry Trends of Sunitinib Malate Capsules
Table 69. Sunitinib Malate Capsules Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Sunitinib Malate Capsules Distributors List
Table 72. Sunitinib Malate Capsules Customer List
Table 73. Global Sunitinib Malate Capsules Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Sunitinib Malate Capsules Sales Market Forecast by Region
Table 75. Global Sunitinib Malate Capsules Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Sunitinib Malate Capsules Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Sunitinib Malate Capsules Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Sunitinib Malate Capsules Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Sunitinib Malate Capsules Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Sunitinib Malate Capsules Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Sunitinib Malate Capsules Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Sunitinib Malate Capsules Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Sunitinib Malate Capsules Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Sunitinib Malate Capsules Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Sunitinib Malate Capsules Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Sunitinib Malate Capsules Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Sunitinib Malate Capsules Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Sunitinib Malate Capsules Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Sunitinib Malate Capsules Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Sunitinib Malate Capsules Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Sunitinib Malate Capsules Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Sunitinib Malate Capsules Revenue Market Share Forecast by Application (2023-2028)
Table 93. Pfizer Sutent Basic Information, Sunitinib Malate Capsules Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Sutent Sunitinib Malate Capsules Product Offered
Table 95. Pfizer Sutent Sunitinib Malate Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Pfizer Sutent Main Business
Table 97. Pfizer Sutent Latest Developments
Table 98. Topcare Pharmaceutical Co., Ltd Basic Information, Sunitinib Malate Capsules Manufacturing Base, Sales Area and Its Competitors
Table 99. Topcare Pharmaceutical Co., Ltd Sunitinib Malate Capsules Product Offered
Table 100. Topcare Pharmaceutical Co., Ltd Sunitinib Malate Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Topcare Pharmaceutical Co., Ltd Main Business
Table 102. Topcare Pharmaceutical Co., Ltd Latest Developments
Table 103. Nanjing First Pharmaceutical Co., Ltd. Basic Information, Sunitinib Malate Capsules Manufacturing Base, Sales Area and Its Competitors
Table 104. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Capsules Product Offered
Table 105. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Nanjing First Pharmaceutical Co., Ltd. Main Business
Table 107. Nanjing First Pharmaceutical Co., Ltd. Latest Developments
Table 108. J&K Scientific Basic Information, Sunitinib Malate Capsules Manufacturing Base, Sales Area and Its Competitors
Table 109. J&K Scientific Sunitinib Malate Capsules Product Offered
Table 110. J&K Scientific Sunitinib Malate Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. J&K Scientific Main Business
Table 112. J&K Scientific Latest Developments
Table 113. Target Molecule Corp. Basic Information, Sunitinib Malate Capsules Manufacturing Base, Sales Area and Its Competitors
Table 114. Target Molecule Corp. Sunitinib Malate Capsules Product Offered
Table 115. Target Molecule Corp. Sunitinib Malate Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Target Molecule Corp. Main Business
Table 117. Target Molecule Corp. Latest Developments
Table 118. Teva Pharmaceuticals USA Basic Information, Sunitinib Malate Capsules Manufacturing Base, Sales Area and Its Competitors
Table 119. Teva Pharmaceuticals USA Sunitinib Malate Capsules Product Offered
Table 120. Teva Pharmaceuticals USA Sunitinib Malate Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Teva Pharmaceuticals USA Main Business
Table 122. Teva Pharmaceuticals USA Latest Developments
Table 123. CSPC Pharmaceutical Group Limited Basic Information, Sunitinib Malate Capsules Manufacturing Base, Sales Area and Its Competitors
Table 124. CSPC Pharmaceutical Group Limited Sunitinib Malate Capsules Product Offered
Table 125. CSPC Pharmaceutical Group Limited Sunitinib Malate Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. CSPC Pharmaceutical Group Limited Main Business
Table 127. CSPC Pharmaceutical Group Limited Latest Developments
List of Figures
Figure 1. Picture of Sunitinib Malate Capsules
Figure 2. Sunitinib Malate Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sunitinib Malate Capsules Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Sunitinib Malate Capsules Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sunitinib Malate Capsules Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity>99%
Figure 10. Product Picture of Purity>98%
Figure 11. Product Picture of Purity>97%
Figure 12. Global Sunitinib Malate Capsules Sales Market Share by Type in 2021
Figure 13. Global Sunitinib Malate Capsules Revenue Market Share by Type (2017-2022)
Figure 14. Sunitinib Malate Capsules Consumed in Advanced Kidney Cancer
Figure 15. Global Sunitinib Malate Capsules Market: Advanced Kidney Cancer (2017-2022) & (K Units)
Figure 16. Sunitinib Malate Capsules Consumed in GIST (Gastrointestinal Stromal Tumor)
Figure 17. Global Sunitinib Malate Capsules Market: GIST (Gastrointestinal Stromal Tumor) (2017-2022) & (K Units)
Figure 18. Sunitinib Malate Capsules Consumed in Pancreatic Neuroendocrine Tumors
Figure 19. Global Sunitinib Malate Capsules Market: Pancreatic Neuroendocrine Tumors (2017-2022) & (K Units)
Figure 20. Sunitinib Malate Capsules Consumed in Others
Figure 21. Global Sunitinib Malate Capsules Market: Others (2017-2022) & (K Units)
Figure 22. Global Sunitinib Malate Capsules Sales Market Share by Application (2017-2022)
Figure 23. Global Sunitinib Malate Capsules Revenue Market Share by Application in 2021
Figure 24. Sunitinib Malate Capsules Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Sunitinib Malate Capsules Revenue Market Share by Company in 2021
Figure 26. Global Sunitinib Malate Capsules Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Sunitinib Malate Capsules Revenue Market Share by Geographic Region in 2021
Figure 28. Global Sunitinib Malate Capsules Sales Market Share by Region (2017-2022)
Figure 29. Global Sunitinib Malate Capsules Revenue Market Share by Country/Region in 2021
Figure 30. Americas Sunitinib Malate Capsules Sales 2017-2022 (K Units)
Figure 31. Americas Sunitinib Malate Capsules Revenue 2017-2022 ($ Millions)
Figure 32. APAC Sunitinib Malate Capsules Sales 2017-2022 (K Units)
Figure 33. APAC Sunitinib Malate Capsules Revenue 2017-2022 ($ Millions)
Figure 34. Europe Sunitinib Malate Capsules Sales 2017-2022 (K Units)
Figure 35. Europe Sunitinib Malate Capsules Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Sunitinib Malate Capsules Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Sunitinib Malate Capsules Revenue 2017-2022 ($ Millions)
Figure 38. Americas Sunitinib Malate Capsules Sales Market Share by Country in 2021
Figure 39. Americas Sunitinib Malate Capsules Revenue Market Share by Country in 2021
Figure 40. United States Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Sunitinib Malate Capsules Sales Market Share by Region in 2021
Figure 45. APAC Sunitinib Malate Capsules Revenue Market Share by Regions in 2021
Figure 46. China Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Sunitinib Malate Capsules Sales Market Share by Country in 2021
Figure 53. Europe Sunitinib Malate Capsules Revenue Market Share by Country in 2021
Figure 54. Germany Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Sunitinib Malate Capsules Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Sunitinib Malate Capsules Revenue Market Share by Country in 2021
Figure 61. Egypt Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Sunitinib Malate Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Sunitinib Malate Capsules in 2021
Figure 67. Manufacturing Process Analysis of Sunitinib Malate Capsules
Figure 68. Industry Chain Structure of Sunitinib Malate Capsules
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy